[1]
|
G. H. Lyman, A. E. Giuliano, M. R. Somerfield, A. B. Benson, D. C. Bodurka, H. J. Burstein, A. J. Cochran, et al., “American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer,” Journal of Clinical Oncology, Vol. 23, No. 30, 2005, pp. 7703-7720.
doi:10.1200/JCO.2005.08.001
|
[2]
|
A. E. Giuliano, P. S. Dale, R. R. Turner, D. L. Morton, S. W. Evans and D. L. Krasne, “Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy,” Annals of Surgery, Vol. 222, No. 3, 1995, pp. 399-401.
doi:10.1097/00000658-199509000-00016
|
[3]
|
N. Wasif, M. A. Maggard, C. Y. Ko and A. E. Giuliano, “Underuse of Axillary Dissection for the Management of Sentinel Node Micrometastases in Breast Cancer,” Archives of Surgery, Vol. 145, No. 2, 2010, pp. 161-166.
doi:10.1001/archsurg.2009.269
|
[4]
|
D. L. Weaver, “Sentinel Lymph Nodes and Breast Carcinoma: Which Micrometastases Are Clinically Significant?” The American Journal of Surgical Pathology, Vol. 27, No. 6, 2003, pp. 842-845.
doi:10.1097/00000478-200306000-00018
|
[5]
|
N. Wasif, X. Ye and A. E. Giuliano, “Survey of ASCO Members on Management of Sentinel Node Micrometastases in Breast Cancer: Variation in Treatment Recommendations According to Specialty,” Annals of Surgical Oncology, Vol. 16, No. 9, 2009, pp. 2442-2449.
doi:10.1245/s10434-009-0549-7
|
[6]
|
S. D. Edge, D. R. Byrd, C. C. Compton, A. G. Fritz, F. L. Greene, A. Trotti, et al., “AJCC Cancer Staging Handbook, From the AJCC Cancer Staging Manual,” 7th Edition, Springer, New York, 2009.
|
[7]
|
M. Hulvat, P. Rajan, E. Rajan, S. Sarker, C. Schermer, G. Aranha, et al., “Histopathologic Characteristics of the Primary Tumor in Breast Cancer Patients with Isolated Tumor Cells of the Sentinel Node,” Surgery, Vol. 144, No. 4, 2008, pp. 518-524. doi:10.1016/j.surg.2008.06.006
|
[8]
|
C. W. Elston, “The Assessment of Histological Differentiation in Breast Cancer,” Australian and New Zealand Journal of Surgery, Vol. 54, No. 1, 1984, pp. 11-15.
doi:10.1111/j.1445-2197.1984.tb06677.x
|
[9]
|
R. R. Turner, K. U. Chu, K. Qi, L. E. Botnick, N M. Hansen, E. C. Glass and A. E. Giuliano, “Pathologic Features Associated with Nonsentinel Lymph Node Metastases in Patients with Metastatic Breast Carcinoma in a Sentinel Lymph Node,” Cancer, Vol. 89, No. 3, 2000, pp. 574-581.
doi:10.1002/1097-0142(20000801)89:3<574::AID-CNCR12>3.0.CO;2-Y
|
[10]
|
M. R Weiser, L. L. Montgomery, L. K. Tan, B. Susnik, D. Y. Leung, P. I. Borgen, et al., “Lymphovascular Invasion Enhances the Prediction of Non-Sentinel Node Metastases in Breast Cancer Patients with Positive Sentinel Nodes,” Annals of Surgical Oncology, Vol. 8, No. 2, 2001, pp. 145-149. doi:10.1007/s10434-001-0145-y
|
[11]
|
K. U. Chu, R. R. Turner, N. M. Hansen, M. B. Brennan, A. Bilchik and A. E. Giuliano, “Do All Patients with Sentinel Node Metastasis from Breast Carcinoma Need Complete Axillary Node Dissection?” Annals of Surgery, Vol. 229, No. 4, 1999, pp. 536-541.
doi:10.1097/00000658-199904000-00013
|
[12]
|
G. Viale, E. Maiorano, G. Mazzarol, S. Zurrida, V. Galimberti, A. Luini, et al., “Histologic Detection and Clinical Implications of Micrometastases in Axillary Sentinel Lymph Nodes for Patients with Breast Carcinoma,” Cancer, Vol. 92, No. 6, 2001, pp. 1378-1384.
doi:10.1002/1097-0142(20010915)92:6<1378::AID-CNCR1460>3.0.CO;2-Y
|
[13]
|
G. Cserni, D. Gregori, F. Merletti, A. Sapino, M. P. Mano, A. Ponti, et al., “Meta-Analysis of Non-Sentinel Node Metastases Associated with Micrometastatic Sentinel Nodes in Breast Cancer,” British Journal of Surgery, Vol. 91, No. 10, 2004, pp. 1245-1252. doi:10.1002/bjs.4725
|
[14]
|
A. E. Giuliano, L. Mccall, P. Beitsch, P. Whitworth, P. Blumencranz, A. Leitch, et al., “Locoregional Recurrence after Sentinel Lymph Node Dissection with or Without Axillary Dissection in Patients with Sentinel Lymph Node Metastases,” Annals of Surgery, Vol. 252, No. 3, 2010, pp. 426-433.
|
[15]
|
C. Aristei, F. Chionne, A. R. Marsella, M. Alessandro, A. Rulli, A. Lemmi, et al., “Evaluation of Level I and II Axillary Nodes Included in the Standard Breast Tangential Fields and Calculation of the Administered Dose, Results of a Prospective Study,” International Journal of Radiation Oncology, Biology and Physics, Vol. 51, No. 1, 2001, pp. 69-73. doi:10.1016/S0360-3016(01)01595-4
|
[16]
|
P. J. Schlembach, T. A. Buchholz, M. I. Ross, S. M. Kirsner, G. J. Salas, E. A. Strom, et al., “Relationship of Sentinel and Axillary Level I-II Lymph Nodes to Tangential Fields Used in Breast Irradiation,” International Journal of Radiation Oncology, Biology and Physics, Vol. 51, No. 3, 2001, pp. 671-678.
doi:10.1016/S0360-3016(01)01684-4
|
[17]
|
J. S. Wong and J. R. Harris, “Postmastectomy Radiation Therapy,” In, J. R. Harris, M. E. Lippman, M. Morrow and C. K. Osborne, Eds., Diseases of the breast, 3rd Edition, Lippincott Williams & Wilkins, Philadelphia, 2004, pp. 785-799.
|